DNA polymerase levels can be altered in human tumors (8); specifically, POLH is upregulated or amplified in melanoma, esophageal and ovarian cancer [28, 32, 53, 54], which contrasts with the HRasG12V-induced depletion we measured above in nontumorigenic cells. Here, POLH is linked to ovarian carcinoma.